Coe Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,724
| Closed | -$604K | – | 77 |
|
|
2019
Q3 | $604K | Buy |
9,724
+350
| +4% | +$21.7K | 0.67% | 57 |
|
|
2019
Q2 | $668K | Sell |
9,374
-66
| -0.7% | -$4.7K | 0.74% | 51 |
|
|
2019
Q1 | $740K | Sell |
9,440
-106
| -1% | -$8.31K | 0.86% | 42 |
|
|
2018
Q4 | $808K | Sell |
9,546
-1,523
| -14% | -$129K | 0.99% | 36 |
|
|
2018
Q3 | $1.9M | Buy |
11,069
+64
| +0.6% | +$11K | 1.87% | 20 |
|
|
2018
Q2 | $1.42M | Hold |
11,005
| – | – | 1.58% | 26 |
|
|
2018
Q1 | $1.13M | Buy |
11,005
+177
| +2% | +$18.2K | 1.23% | 36 |
|
|
2017
Q4 | $925K | Sell |
10,828
-337
| -3% | -$28.8K | 0.98% | 44 |
|
|
2017
Q3 | $948K | Buy |
+11,165
| New | +$948K | 0.99% | 41 |
|